Pharma & Healthcare
Global Voriconazole Market Research Report 2025
- Mar 11, 25
- ID: 7473
- Pages: 99
- Figures: 102
- Views: 8
The global market for Voriconazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Voriconazole is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Voriconazole is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Voriconazole include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo, GSK, Cilag AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Voriconazole.
The Voriconazole market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Voriconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Voriconazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals
Segment by Type
Injection Voriconazole
Voriconazole Freeze-dried Powder
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Voriconazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Voriconazole is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Voriconazole is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Voriconazole include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo, GSK, Cilag AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Voriconazole.
The Voriconazole market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Voriconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Voriconazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals
Segment by Type
Injection Voriconazole
Voriconazole Freeze-dried Powder
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Voriconazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Voriconazole Market Overview
1.1 Product Definition
1.2 Voriconazole by Type
1.2.1 Global Voriconazole Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection Voriconazole
1.2.3 Voriconazole Freeze-dried Powder
1.3 Voriconazole by Application
1.3.1 Global Voriconazole Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Voriconazole Market Size Estimates and Forecasts
1.4.1 Global Voriconazole Revenue 2020-2031
1.4.2 Global Voriconazole Sales 2020-2031
1.4.3 Global Voriconazole Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Voriconazole Market Competition by Manufacturers
2.1 Global Voriconazole Sales Market Share by Manufacturers (2020-2025)
2.2 Global Voriconazole Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Voriconazole Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Voriconazole, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Voriconazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Voriconazole, Product Type & Application
2.7 Global Key Manufacturers of Voriconazole, Date of Enter into This Industry
2.8 Global Voriconazole Market Competitive Situation and Trends
2.8.1 Global Voriconazole Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Voriconazole Players Market Share by Revenue
2.8.3 Global Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Voriconazole Market Scenario by Region
3.1 Global Voriconazole Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Voriconazole Sales by Region: 2020-2031
3.2.1 Global Voriconazole Sales by Region: 2020-2025
3.2.2 Global Voriconazole Sales by Region: 2026-2031
3.3 Global Voriconazole Revenue by Region: 2020-2031
3.3.1 Global Voriconazole Revenue by Region: 2020-2025
3.3.2 Global Voriconazole Revenue by Region: 2026-2031
3.4 North America Voriconazole Market Facts & Figures by Country
3.4.1 North America Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Voriconazole Sales by Country (2020-2031)
3.4.3 North America Voriconazole Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Voriconazole Market Facts & Figures by Country
3.5.1 Europe Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Voriconazole Sales by Country (2020-2031)
3.5.3 Europe Voriconazole Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Voriconazole Market Facts & Figures by Region
3.6.1 Asia Pacific Voriconazole Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Voriconazole Sales by Region (2020-2031)
3.6.3 Asia Pacific Voriconazole Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Voriconazole Market Facts & Figures by Country
3.7.1 Latin America Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Voriconazole Sales by Country (2020-2031)
3.7.3 Latin America Voriconazole Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Voriconazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Voriconazole Sales by Country (2020-2031)
3.8.3 Middle East and Africa Voriconazole Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Voriconazole Sales by Type (2020-2031)
4.1.1 Global Voriconazole Sales by Type (2020-2025)
4.1.2 Global Voriconazole Sales by Type (2026-2031)
4.1.3 Global Voriconazole Sales Market Share by Type (2020-2031)
4.2 Global Voriconazole Revenue by Type (2020-2031)
4.2.1 Global Voriconazole Revenue by Type (2020-2025)
4.2.2 Global Voriconazole Revenue by Type (2026-2031)
4.2.3 Global Voriconazole Revenue Market Share by Type (2020-2031)
4.3 Global Voriconazole Price by Type (2020-2031)
5 Segment by Application
5.1 Global Voriconazole Sales by Application (2020-2031)
5.1.1 Global Voriconazole Sales by Application (2020-2025)
5.1.2 Global Voriconazole Sales by Application (2026-2031)
5.1.3 Global Voriconazole Sales Market Share by Application (2020-2031)
5.2 Global Voriconazole Revenue by Application (2020-2031)
5.2.1 Global Voriconazole Revenue by Application (2020-2025)
5.2.2 Global Voriconazole Revenue by Application (2026-2031)
5.2.3 Global Voriconazole Revenue Market Share by Application (2020-2031)
5.3 Global Voriconazole Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Voriconazole Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Voriconazole Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 GeneTech Pharm
6.3.1 GeneTech Pharm Company Information
6.3.2 GeneTech Pharm Description and Business Overview
6.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GeneTech Pharm Voriconazole Product Portfolio
6.3.5 GeneTech Pharm Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Voriconazole Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Voriconazole Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Company Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Squibb Voriconazole Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Sandoz
6.7.1 Sandoz Company Information
6.7.2 Sandoz Description and Business Overview
6.7.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sandoz Voriconazole Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Company Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Daiichi Sankyo Voriconazole Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GSK Voriconazole Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Cilag AG
6.10.1 Cilag AG Company Information
6.10.2 Cilag AG Description and Business Overview
6.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cilag AG Voriconazole Product Portfolio
6.10.5 Cilag AG Recent Developments/Updates
6.11 Macherey-Nagel GmbH
6.11.1 Macherey-Nagel GmbH Company Information
6.11.2 Macherey-Nagel GmbH Description and Business Overview
6.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
6.11.5 Macherey-Nagel GmbH Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Company Information
6.12.2 Abbott Description and Business Overview
6.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Abbott Voriconazole Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Company Information
6.13.2 Takeda Description and Business Overview
6.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Takeda Voriconazole Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Sichuan Beauty Sport Huakang Pharmaceutical
6.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
6.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Description and Business Overview
6.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
6.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments/Updates
6.15 Jincheng HEALTH Pharmaceutical
6.15.1 Jincheng HEALTH Pharmaceutical Company Information
6.15.2 Jincheng HEALTH Pharmaceutical Description and Business Overview
6.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
6.15.5 Jincheng HEALTH Pharmaceutical Recent Developments/Updates
6.16 Ebang Pharmaceutical
6.16.1 Ebang Pharmaceutical Company Information
6.16.2 Ebang Pharmaceutical Description and Business Overview
6.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Ebang Pharmaceutical Voriconazole Product Portfolio
6.16.5 Ebang Pharmaceutical Recent Developments/Updates
6.17 Aditya Pharma
6.17.1 Aditya Pharma Company Information
6.17.2 Aditya Pharma Description and Business Overview
6.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Aditya Pharma Voriconazole Product Portfolio
6.17.5 Aditya Pharma Recent Developments/Updates
6.18 Taj Pharmaceuticals
6.18.1 Taj Pharmaceuticals Company Information
6.18.2 Taj Pharmaceuticals Description and Business Overview
6.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Taj Pharmaceuticals Voriconazole Product Portfolio
6.18.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Voriconazole Industry Chain Analysis
7.2 Voriconazole Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Voriconazole Production Mode & Process Analysis
7.4 Voriconazole Sales and Marketing
7.4.1 Voriconazole Sales Channels
7.4.2 Voriconazole Distributors
7.5 Voriconazole Customer Analysis
8 Voriconazole Market Dynamics
8.1 Voriconazole Industry Trends
8.2 Voriconazole Market Drivers
8.3 Voriconazole Market Challenges
8.4 Voriconazole Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Voriconazole by Type
1.2.1 Global Voriconazole Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection Voriconazole
1.2.3 Voriconazole Freeze-dried Powder
1.3 Voriconazole by Application
1.3.1 Global Voriconazole Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Voriconazole Market Size Estimates and Forecasts
1.4.1 Global Voriconazole Revenue 2020-2031
1.4.2 Global Voriconazole Sales 2020-2031
1.4.3 Global Voriconazole Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Voriconazole Market Competition by Manufacturers
2.1 Global Voriconazole Sales Market Share by Manufacturers (2020-2025)
2.2 Global Voriconazole Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Voriconazole Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Voriconazole, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Voriconazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Voriconazole, Product Type & Application
2.7 Global Key Manufacturers of Voriconazole, Date of Enter into This Industry
2.8 Global Voriconazole Market Competitive Situation and Trends
2.8.1 Global Voriconazole Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Voriconazole Players Market Share by Revenue
2.8.3 Global Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Voriconazole Market Scenario by Region
3.1 Global Voriconazole Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Voriconazole Sales by Region: 2020-2031
3.2.1 Global Voriconazole Sales by Region: 2020-2025
3.2.2 Global Voriconazole Sales by Region: 2026-2031
3.3 Global Voriconazole Revenue by Region: 2020-2031
3.3.1 Global Voriconazole Revenue by Region: 2020-2025
3.3.2 Global Voriconazole Revenue by Region: 2026-2031
3.4 North America Voriconazole Market Facts & Figures by Country
3.4.1 North America Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Voriconazole Sales by Country (2020-2031)
3.4.3 North America Voriconazole Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Voriconazole Market Facts & Figures by Country
3.5.1 Europe Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Voriconazole Sales by Country (2020-2031)
3.5.3 Europe Voriconazole Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Voriconazole Market Facts & Figures by Region
3.6.1 Asia Pacific Voriconazole Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Voriconazole Sales by Region (2020-2031)
3.6.3 Asia Pacific Voriconazole Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Voriconazole Market Facts & Figures by Country
3.7.1 Latin America Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Voriconazole Sales by Country (2020-2031)
3.7.3 Latin America Voriconazole Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Voriconazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Voriconazole Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Voriconazole Sales by Country (2020-2031)
3.8.3 Middle East and Africa Voriconazole Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Voriconazole Sales by Type (2020-2031)
4.1.1 Global Voriconazole Sales by Type (2020-2025)
4.1.2 Global Voriconazole Sales by Type (2026-2031)
4.1.3 Global Voriconazole Sales Market Share by Type (2020-2031)
4.2 Global Voriconazole Revenue by Type (2020-2031)
4.2.1 Global Voriconazole Revenue by Type (2020-2025)
4.2.2 Global Voriconazole Revenue by Type (2026-2031)
4.2.3 Global Voriconazole Revenue Market Share by Type (2020-2031)
4.3 Global Voriconazole Price by Type (2020-2031)
5 Segment by Application
5.1 Global Voriconazole Sales by Application (2020-2031)
5.1.1 Global Voriconazole Sales by Application (2020-2025)
5.1.2 Global Voriconazole Sales by Application (2026-2031)
5.1.3 Global Voriconazole Sales Market Share by Application (2020-2031)
5.2 Global Voriconazole Revenue by Application (2020-2031)
5.2.1 Global Voriconazole Revenue by Application (2020-2025)
5.2.2 Global Voriconazole Revenue by Application (2026-2031)
5.2.3 Global Voriconazole Revenue Market Share by Application (2020-2031)
5.3 Global Voriconazole Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Voriconazole Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Voriconazole Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 GeneTech Pharm
6.3.1 GeneTech Pharm Company Information
6.3.2 GeneTech Pharm Description and Business Overview
6.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GeneTech Pharm Voriconazole Product Portfolio
6.3.5 GeneTech Pharm Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Voriconazole Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Voriconazole Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Company Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Squibb Voriconazole Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Sandoz
6.7.1 Sandoz Company Information
6.7.2 Sandoz Description and Business Overview
6.7.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sandoz Voriconazole Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Company Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Daiichi Sankyo Voriconazole Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GSK Voriconazole Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Cilag AG
6.10.1 Cilag AG Company Information
6.10.2 Cilag AG Description and Business Overview
6.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cilag AG Voriconazole Product Portfolio
6.10.5 Cilag AG Recent Developments/Updates
6.11 Macherey-Nagel GmbH
6.11.1 Macherey-Nagel GmbH Company Information
6.11.2 Macherey-Nagel GmbH Description and Business Overview
6.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
6.11.5 Macherey-Nagel GmbH Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Company Information
6.12.2 Abbott Description and Business Overview
6.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Abbott Voriconazole Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Company Information
6.13.2 Takeda Description and Business Overview
6.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Takeda Voriconazole Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Sichuan Beauty Sport Huakang Pharmaceutical
6.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
6.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Description and Business Overview
6.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
6.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments/Updates
6.15 Jincheng HEALTH Pharmaceutical
6.15.1 Jincheng HEALTH Pharmaceutical Company Information
6.15.2 Jincheng HEALTH Pharmaceutical Description and Business Overview
6.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
6.15.5 Jincheng HEALTH Pharmaceutical Recent Developments/Updates
6.16 Ebang Pharmaceutical
6.16.1 Ebang Pharmaceutical Company Information
6.16.2 Ebang Pharmaceutical Description and Business Overview
6.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Ebang Pharmaceutical Voriconazole Product Portfolio
6.16.5 Ebang Pharmaceutical Recent Developments/Updates
6.17 Aditya Pharma
6.17.1 Aditya Pharma Company Information
6.17.2 Aditya Pharma Description and Business Overview
6.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Aditya Pharma Voriconazole Product Portfolio
6.17.5 Aditya Pharma Recent Developments/Updates
6.18 Taj Pharmaceuticals
6.18.1 Taj Pharmaceuticals Company Information
6.18.2 Taj Pharmaceuticals Description and Business Overview
6.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Taj Pharmaceuticals Voriconazole Product Portfolio
6.18.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Voriconazole Industry Chain Analysis
7.2 Voriconazole Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Voriconazole Production Mode & Process Analysis
7.4 Voriconazole Sales and Marketing
7.4.1 Voriconazole Sales Channels
7.4.2 Voriconazole Distributors
7.5 Voriconazole Customer Analysis
8 Voriconazole Market Dynamics
8.1 Voriconazole Industry Trends
8.2 Voriconazole Market Drivers
8.3 Voriconazole Market Challenges
8.4 Voriconazole Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Voriconazole Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Voriconazole Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Voriconazole Market Competitive Situation by Manufacturers in 2024
Table 4. Global Voriconazole Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Voriconazole Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Voriconazole Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Voriconazole Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Voriconazole Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Voriconazole, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Voriconazole, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Voriconazole, Product Type & Application
Table 12. Global Key Manufacturers of Voriconazole, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Voriconazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Voriconazole as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Voriconazole Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Voriconazole Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Voriconazole Sales Market Share by Region (2020-2025)
Table 19. Global Voriconazole Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Voriconazole Sales Market Share by Region (2026-2031)
Table 21. Global Voriconazole Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Voriconazole Revenue Market Share by Region (2020-2025)
Table 23. Global Voriconazole Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Voriconazole Revenue Market Share by Region (2026-2031)
Table 25. North America Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Voriconazole Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Voriconazole Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Voriconazole Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Voriconazole Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Voriconazole Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Voriconazole Sales (K Pcs) by Type (2020-2025)
Table 51. Global Voriconazole Sales (K Pcs) by Type (2026-2031)
Table 52. Global Voriconazole Sales Market Share by Type (2020-2025)
Table 53. Global Voriconazole Sales Market Share by Type (2026-2031)
Table 54. Global Voriconazole Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Voriconazole Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Voriconazole Revenue Market Share by Type (2020-2025)
Table 57. Global Voriconazole Revenue Market Share by Type (2026-2031)
Table 58. Global Voriconazole Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Voriconazole Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Voriconazole Sales (K Pcs) by Application (2020-2025)
Table 61. Global Voriconazole Sales (K Pcs) by Application (2026-2031)
Table 62. Global Voriconazole Sales Market Share by Application (2020-2025)
Table 63. Global Voriconazole Sales Market Share by Application (2026-2031)
Table 64. Global Voriconazole Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Voriconazole Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Voriconazole Revenue Market Share by Application (2020-2025)
Table 67. Global Voriconazole Revenue Market Share by Application (2026-2031)
Table 68. Global Voriconazole Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Voriconazole Price (USD/Pcs) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Pfizer Voriconazole Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Teva Voriconazole Product
Table 79. Teva Recent Developments/Updates
Table 80. GeneTech Pharm Company Information
Table 81. GeneTech Pharm Description and Business Overview
Table 82. GeneTech Pharm Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. GeneTech Pharm Voriconazole Product
Table 84. GeneTech Pharm Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Novartis Voriconazole Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Mylan Voriconazole Product
Table 94. Mylan Recent Developments/Updates
Table 95. Squibb Company Information
Table 96. Squibb Description and Business Overview
Table 97. Squibb Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Squibb Voriconazole Product
Table 99. Squibb Recent Developments/Updates
Table 100. Sandoz Company Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Sandoz Voriconazole Product
Table 104. Sandoz Recent Developments/Updates
Table 105. Daiichi Sankyo Company Information
Table 106. Daiichi Sankyo Description and Business Overview
Table 107. Daiichi Sankyo Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Daiichi Sankyo Voriconazole Product
Table 109. Daiichi Sankyo Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. GSK Voriconazole Product
Table 114. GSK Recent Developments/Updates
Table 115. Cilag AG Company Information
Table 116. Cilag AG Description and Business Overview
Table 117. Cilag AG Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Cilag AG Voriconazole Product
Table 119. Cilag AG Recent Developments/Updates
Table 120. Macherey-Nagel GmbH Company Information
Table 121. Macherey-Nagel GmbH Description and Business Overview
Table 122. Macherey-Nagel GmbH Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Macherey-Nagel GmbH Voriconazole Product
Table 124. Macherey-Nagel GmbH Recent Developments/Updates
Table 125. Abbott Company Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Abbott Voriconazole Product
Table 129. Abbott Recent Developments/Updates
Table 130. Takeda Company Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Takeda Voriconazole Product
Table 134. Takeda Recent Developments/Updates
Table 135. Sichuan Beauty Sport Huakang Pharmaceutical Company Information
Table 136. Sichuan Beauty Sport Huakang Pharmaceutical Description and Business Overview
Table 137. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product
Table 139. Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments/Updates
Table 140. Jincheng HEALTH Pharmaceutical Company Information
Table 141. Jincheng HEALTH Pharmaceutical Description and Business Overview
Table 142. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Jincheng HEALTH Pharmaceutical Voriconazole Product
Table 144. Jincheng HEALTH Pharmaceutical Recent Developments/Updates
Table 145. Ebang Pharmaceutical Company Information
Table 146. Ebang Pharmaceutical Description and Business Overview
Table 147. Ebang Pharmaceutical Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Ebang Pharmaceutical Voriconazole Product
Table 149. Ebang Pharmaceutical Recent Developments/Updates
Table 150. Aditya Pharma Company Information
Table 151. Aditya Pharma Description and Business Overview
Table 152. Aditya Pharma Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Aditya Pharma Voriconazole Product
Table 154. Aditya Pharma Recent Developments/Updates
Table 155. Taj Pharmaceuticals Company Information
Table 156. Taj Pharmaceuticals Description and Business Overview
Table 157. Taj Pharmaceuticals Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Taj Pharmaceuticals Voriconazole Product
Table 159. Taj Pharmaceuticals Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Voriconazole Distributors List
Table 163. Voriconazole Customers List
Table 164. Voriconazole Market Trends
Table 165. Voriconazole Market Drivers
Table 166. Voriconazole Market Challenges
Table 167. Voriconazole Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Voriconazole
Figure 2. Global Voriconazole Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Voriconazole Market Share by Type: 2024 & 2031
Figure 4. Injection Voriconazole Product Picture
Figure 5. Voriconazole Freeze-dried Powder Product Picture
Figure 6. Global Voriconazole Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Voriconazole Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Voriconazole Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Voriconazole Market Size (2020-2031) & (US$ Million)
Figure 13. Global Voriconazole Sales (2020-2031) & (K Pcs)
Figure 14. Global Voriconazole Average Price (USD/Pcs) & (2020-2031)
Figure 15. Voriconazole Report Years Considered
Figure 16. Voriconazole Sales Share by Manufacturers in 2024
Figure 17. Global Voriconazole Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Voriconazole Players: Market Share by Revenue in Voriconazole in 2024
Figure 19. Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Voriconazole Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Voriconazole Sales Market Share by Country (2020-2031)
Figure 22. North America Voriconazole Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Voriconazole Sales Market Share by Country (2020-2031)
Figure 26. Europe Voriconazole Revenue Market Share by Country (2020-2031)
Figure 27. Germany Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Voriconazole Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Voriconazole Revenue Market Share by Region (2020-2031)
Figure 34. China Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Voriconazole Sales Market Share by Country (2020-2031)
Figure 45. Latin America Voriconazole Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Voriconazole Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Voriconazole Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Voriconazole by Type (2020-2031)
Figure 55. Global Revenue Market Share of Voriconazole by Type (2020-2031)
Figure 56. Global Voriconazole Price (USD/Pcs) by Type (2020-2031)
Figure 57. Global Sales Market Share of Voriconazole by Application (2020-2031)
Figure 58. Global Revenue Market Share of Voriconazole by Application (2020-2031)
Figure 59. Global Voriconazole Price (USD/Pcs) by Application (2020-2031)
Figure 60. Voriconazole Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Voriconazole Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Voriconazole Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Voriconazole Market Competitive Situation by Manufacturers in 2024
Table 4. Global Voriconazole Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Voriconazole Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Voriconazole Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Voriconazole Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Voriconazole Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Voriconazole, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Voriconazole, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Voriconazole, Product Type & Application
Table 12. Global Key Manufacturers of Voriconazole, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Voriconazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Voriconazole as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Voriconazole Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Voriconazole Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Voriconazole Sales Market Share by Region (2020-2025)
Table 19. Global Voriconazole Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Voriconazole Sales Market Share by Region (2026-2031)
Table 21. Global Voriconazole Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Voriconazole Revenue Market Share by Region (2020-2025)
Table 23. Global Voriconazole Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Voriconazole Revenue Market Share by Region (2026-2031)
Table 25. North America Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Voriconazole Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Voriconazole Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Voriconazole Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Voriconazole Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Voriconazole Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Voriconazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Voriconazole Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Voriconazole Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Voriconazole Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Voriconazole Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Voriconazole Sales (K Pcs) by Type (2020-2025)
Table 51. Global Voriconazole Sales (K Pcs) by Type (2026-2031)
Table 52. Global Voriconazole Sales Market Share by Type (2020-2025)
Table 53. Global Voriconazole Sales Market Share by Type (2026-2031)
Table 54. Global Voriconazole Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Voriconazole Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Voriconazole Revenue Market Share by Type (2020-2025)
Table 57. Global Voriconazole Revenue Market Share by Type (2026-2031)
Table 58. Global Voriconazole Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Voriconazole Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Voriconazole Sales (K Pcs) by Application (2020-2025)
Table 61. Global Voriconazole Sales (K Pcs) by Application (2026-2031)
Table 62. Global Voriconazole Sales Market Share by Application (2020-2025)
Table 63. Global Voriconazole Sales Market Share by Application (2026-2031)
Table 64. Global Voriconazole Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Voriconazole Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Voriconazole Revenue Market Share by Application (2020-2025)
Table 67. Global Voriconazole Revenue Market Share by Application (2026-2031)
Table 68. Global Voriconazole Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Voriconazole Price (USD/Pcs) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Pfizer Voriconazole Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Teva Voriconazole Product
Table 79. Teva Recent Developments/Updates
Table 80. GeneTech Pharm Company Information
Table 81. GeneTech Pharm Description and Business Overview
Table 82. GeneTech Pharm Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. GeneTech Pharm Voriconazole Product
Table 84. GeneTech Pharm Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Novartis Voriconazole Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Mylan Voriconazole Product
Table 94. Mylan Recent Developments/Updates
Table 95. Squibb Company Information
Table 96. Squibb Description and Business Overview
Table 97. Squibb Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Squibb Voriconazole Product
Table 99. Squibb Recent Developments/Updates
Table 100. Sandoz Company Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Sandoz Voriconazole Product
Table 104. Sandoz Recent Developments/Updates
Table 105. Daiichi Sankyo Company Information
Table 106. Daiichi Sankyo Description and Business Overview
Table 107. Daiichi Sankyo Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Daiichi Sankyo Voriconazole Product
Table 109. Daiichi Sankyo Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. GSK Voriconazole Product
Table 114. GSK Recent Developments/Updates
Table 115. Cilag AG Company Information
Table 116. Cilag AG Description and Business Overview
Table 117. Cilag AG Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Cilag AG Voriconazole Product
Table 119. Cilag AG Recent Developments/Updates
Table 120. Macherey-Nagel GmbH Company Information
Table 121. Macherey-Nagel GmbH Description and Business Overview
Table 122. Macherey-Nagel GmbH Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Macherey-Nagel GmbH Voriconazole Product
Table 124. Macherey-Nagel GmbH Recent Developments/Updates
Table 125. Abbott Company Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Abbott Voriconazole Product
Table 129. Abbott Recent Developments/Updates
Table 130. Takeda Company Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Takeda Voriconazole Product
Table 134. Takeda Recent Developments/Updates
Table 135. Sichuan Beauty Sport Huakang Pharmaceutical Company Information
Table 136. Sichuan Beauty Sport Huakang Pharmaceutical Description and Business Overview
Table 137. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product
Table 139. Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments/Updates
Table 140. Jincheng HEALTH Pharmaceutical Company Information
Table 141. Jincheng HEALTH Pharmaceutical Description and Business Overview
Table 142. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Jincheng HEALTH Pharmaceutical Voriconazole Product
Table 144. Jincheng HEALTH Pharmaceutical Recent Developments/Updates
Table 145. Ebang Pharmaceutical Company Information
Table 146. Ebang Pharmaceutical Description and Business Overview
Table 147. Ebang Pharmaceutical Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Ebang Pharmaceutical Voriconazole Product
Table 149. Ebang Pharmaceutical Recent Developments/Updates
Table 150. Aditya Pharma Company Information
Table 151. Aditya Pharma Description and Business Overview
Table 152. Aditya Pharma Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Aditya Pharma Voriconazole Product
Table 154. Aditya Pharma Recent Developments/Updates
Table 155. Taj Pharmaceuticals Company Information
Table 156. Taj Pharmaceuticals Description and Business Overview
Table 157. Taj Pharmaceuticals Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Taj Pharmaceuticals Voriconazole Product
Table 159. Taj Pharmaceuticals Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Voriconazole Distributors List
Table 163. Voriconazole Customers List
Table 164. Voriconazole Market Trends
Table 165. Voriconazole Market Drivers
Table 166. Voriconazole Market Challenges
Table 167. Voriconazole Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Voriconazole
Figure 2. Global Voriconazole Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Voriconazole Market Share by Type: 2024 & 2031
Figure 4. Injection Voriconazole Product Picture
Figure 5. Voriconazole Freeze-dried Powder Product Picture
Figure 6. Global Voriconazole Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Voriconazole Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Voriconazole Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Voriconazole Market Size (2020-2031) & (US$ Million)
Figure 13. Global Voriconazole Sales (2020-2031) & (K Pcs)
Figure 14. Global Voriconazole Average Price (USD/Pcs) & (2020-2031)
Figure 15. Voriconazole Report Years Considered
Figure 16. Voriconazole Sales Share by Manufacturers in 2024
Figure 17. Global Voriconazole Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Voriconazole Players: Market Share by Revenue in Voriconazole in 2024
Figure 19. Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Voriconazole Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Voriconazole Sales Market Share by Country (2020-2031)
Figure 22. North America Voriconazole Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Voriconazole Sales Market Share by Country (2020-2031)
Figure 26. Europe Voriconazole Revenue Market Share by Country (2020-2031)
Figure 27. Germany Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Voriconazole Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Voriconazole Revenue Market Share by Region (2020-2031)
Figure 34. China Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Voriconazole Sales Market Share by Country (2020-2031)
Figure 45. Latin America Voriconazole Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Voriconazole Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Voriconazole Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Voriconazole Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Voriconazole by Type (2020-2031)
Figure 55. Global Revenue Market Share of Voriconazole by Type (2020-2031)
Figure 56. Global Voriconazole Price (USD/Pcs) by Type (2020-2031)
Figure 57. Global Sales Market Share of Voriconazole by Application (2020-2031)
Figure 58. Global Revenue Market Share of Voriconazole by Application (2020-2031)
Figure 59. Global Voriconazole Price (USD/Pcs) by Application (2020-2031)
Figure 60. Voriconazole Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232